Valeos Pharma A/S Financials, key figures and credit report
Gross profit 975.9 kDKK FY 2025 +125.4% vs 2024
EBIT -13 741.4 kDKK FY 2025 +21.6% vs 2024
Net debt 50 604.9 kDKK FY 2025 +10.3% vs 2024
Quick ratio 0.2 FY 2025 -0.2 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -3 377.00 | -5 901.90 | -5 838.51 | -3 846.79 | 975.95 |
| Employee benefit expenses | -4 015.00 | -9 038.53 | -9 038.53 | -10 558.63 | -11 603.89 |
| Total depreciation | -20.00 | -2 354.40 | -2 354.40 | -3 113.59 | -3 113.42 |
| EBIT | -7 412.00 | -17 294.83 | -17 231.43 | -17 519.01 | -13 741.36 |
| Other financial income | 0.61 | ||||
| Other financial expenses | - 797.00 | -3 873.17 | -3 936.56 | -4 181.99 | -3 411.18 |
| Pre-tax profit | -8 209.00 | -21 168.00 | -21 168.00 | -21 701.00 | -17 151.94 |
| Income taxes | 1 801.00 | 4 634.01 | 4 634.01 | 4 756.29 | 3 664.57 |
| Net earnings | -6 408.00 | -16 533.98 | -16 533.98 | -16 944.71 | -13 487.36 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Buildings | 1.00 | 49 200.10 | 49 200.10 | 46 215.08 | 43 184.52 |
| Machinery and equipment | 161.00 | 259.07 | 259.07 | 176.21 | 93.34 |
| Advance payments and construction in progress | 40 307.00 | ||||
| Tangible assets total | 40 469.00 | 49 459.16 | 49 459.16 | 46 391.29 | 43 277.87 |
| Investments total | 431.41 | 433.58 | 449.10 | ||
| Non-current other receivables | 333.00 | 431.41 | |||
| Long term receivables total | 333.00 | 431.41 | |||
| Semifinished products | 463.34 | 463.34 | 1 152.95 | 769.72 | |
| Raw materials and consumables | 112.15 | 140.23 | |||
| Finished products/goods | 1 021.50 | 1 021.50 | 1 457.84 | 1 913.14 | |
| Inventories total | 1 484.84 | 1 484.84 | 2 722.95 | 2 823.10 | |
| Current trade debtors | 248.56 | 61.17 | |||
| Prepayments and accrued income | 160.00 | 451.95 | 451.95 | 755.53 | 456.39 |
| Current other receivables | 1 815.00 | 1 866.20 | 1 866.20 | 1 382.49 | 1 088.56 |
| Current deferred tax assets | 1 807.00 | 7 401.54 | 7 401.54 | 6 209.25 | 4 681.81 |
| Short term receivables total | 3 782.00 | 9 719.69 | 9 719.69 | 8 595.83 | 6 287.94 |
| Cash and bank deposits | 5 359.00 | ||||
| Cash and cash equivalents | 5 359.00 | ||||
| Balance sheet total (assets) | 49 943.00 | 61 095.10 | 61 095.10 | 58 143.64 | 52 838.01 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 515.00 | 526.69 | 526.69 | 802.63 | 802.63 |
| Share premium account | 140.00 | 140.00 | 140.00 | 140.00 | 140.00 |
| Retained earnings | 22 285.00 | 7 439.25 | 7 439.25 | 22 802.27 | 5 857.56 |
| Profit of the financial year | -6 408.00 | -16 533.98 | -16 533.98 | -16 944.71 | -13 487.36 |
| Shareholders equity total | 16 532.00 | -8 428.04 | -8 428.04 | 6 800.20 | -6 687.17 |
| Provisions | 6.00 | 1 153.72 | 2 322.25 | ||
| Capital loans | 22 729.00 | 26 566.64 | 26 566.64 | 24 980.85 | 23 460.00 |
| Non-current loans from credit institutions | 8 232.00 | 16 366.57 | 19 786.59 | 1 897.02 | 4 986.39 |
| Non-current other liabilities | 147.00 | 3 576.97 | 156.95 | 2 793.61 | 1 820.66 |
| Non-current liabilities total | 31 108.00 | 46 510.19 | 46 510.19 | 29 671.48 | 30 267.05 |
| Current loans from credit institutions | 17 650.58 | 17 650.58 | 18 771.64 | 19 501.94 | |
| Current trade creditors | 1 583.00 | 4 529.71 | 4 529.70 | 1 093.58 | 4 235.79 |
| Current owed to participating | 208.00 | 216.49 | 216.49 | 220.82 | 225.23 |
| Current owed to group member | 2 431.39 | ||||
| Other non-interest bearing current liabilities | 506.00 | 616.18 | 616.19 | 432.21 | 541.53 |
| Current liabilities total | 2 297.00 | 23 012.95 | 23 012.95 | 20 518.24 | 26 935.87 |
| Balance sheet total (liabilities) | 49 943.00 | 61 095.10 | 61 095.10 | 58 143.64 | 52 838.01 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated